HIV Post Exposure Prophylaxis: prospects, opportunities and challenges
- PMID: 40569861
- PMCID: PMC12231641
- DOI: 10.1002/jia2.26511
HIV Post Exposure Prophylaxis: prospects, opportunities and challenges
Conflict of interest statement
AUTHORS’ CONTRIBUTIONS
JF and ELS contributed to the initial draft of the manuscript. PG‐F provided feedback, reviewed and edited the draft, and approved the final version prior to submission.
References
-
- UNAIDS . Fact Sheet 2024: Global HIV Statistics. Geneva: UNAIDS; 2024.
-
- UNAIDS . 2024 Global AIDS Update: The Urgency of Now—AIDS at a Crossroads. Geneva: UNAIDS; 2024.
-
- Tsai C‐C, Emau P, Follis KE, Beck TW, Benveniste RE, Bischofberger N, et al. Effectiveness of postinoculation (R)‐9‐(2‐phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol. 1998;72(5):4265–73. - PMC - PubMed
-
- Irvine C, Egan KJ, Shubber Z, Van Rompay KK, Beanland RL, Ford N. Efficacy of HIV postexposure prophylaxis: systematic review and meta‐analysis of nonhuman primate studies. Clin Infect Dis. 2015;60 Suppl 3:S165–9. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
